过去一年中添加的文章,按日期排序

Can Patients With COPD Achieve and Maintain Disease Stability With Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Dual …

D Singh, C Compton, R Sharma… - B52. EVIDENCE FOR …, 2024 - atsjournals.org
51 天前 - … exacerbations in patients receiving single-inhaler triple therapy (SITT) fluticasone
furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus inhaled corticosteroid/long-acting β2-…

SWIFT-1 and SWIFT-2 Study Design: Replicate Phase 3A Randomized, Double-blind, Placebo-controlled, Multicenter Studies of the Efficacy and Safety of …

ID Pavord, D Jackson, M Wechsler… - … THERAPY IN THE …, 2024 - atsjournals.org
51 天前 - … in patients at risk of exacerbations with … inhaled corticosteroids in the 12 months
before screening and ≥1 additional controller medication (with or without oral corticosteroids) …

Associations of COPD and Related Outcomes With COVID-19 Hospitalization or Death: The C4R, Copdgene, and Spiromics Studies

AM Rusk, P Balte, N Allen, RG Barr… - C107. MICROBIAL …, 2024 - atsjournals.org
51 天前 - … studies identified COPD as a risk factor for severe COVID-… severity, and use of
inhaled corticosteroids (ICS). Methods: … are most at risk for severe COVID-19 to better inform risk

Predictors of Hospitalization for Patients With Severe Asthma: An Update Since the COVID-19 Pandemic

N Seshadri, W Faig, LR Young… - C17. PEDIATRIC IMPACT …, 2024 - atsjournals.org
51 天前 - … with high dose inhaled corticosteroids. Children with severe asthma are at risk of
… , or have public insurance remain at higher risk of future hospitalization for asthma even …

Fractional Concentration of Exhaled Nitric Oxide (FeNO) by HIV Status in Men and Women in the MACS-WIHS Combined Cohort Study

M Wilson, A Edmonds, MB Drummond… - B67. VIRAL …, 2024 - atsjournals.org
51 天前 - … whether HIV independently increases risk for asthma. A … As expected, current
smoking and inhaled corticosteroid … , and seronegative controls at risk for HIV acquisition rather …

Ensifentrine Added on to LABA/ICS Therapy Improved Lung Function and Reduced Exacerbations in Symptomatic Subjects With Moderate-to-Severe COPD

N Marchetti, R Kalhan, MT Dransfield… - B52. EVIDENCE FOR …, 2024 - atsjournals.org
51 天前 - … long-acting beta2-agonist/inhaled corticosteroid (LABA/ICS) for maintenance treatment
… in lung function and reduction in exacerbation rate and risk in subjects with moderate-to-…

Frequent Productive Cough in COPD Patients Without Exacerbation History Is Associated With Increased Risk of Exacerbations and a Treatment Benefit From …

J Marshall, FJ Martinez, GT Ferguson… - A48. COPD …, 2024 - atsjournals.org
51 天前 - … In the KRONOS study, inhaled corticosteroid (ICS)/longacting muscarinic
antagonist (LAMA)/long-acting β2-agonist (LABA) triple therapy with budesonide/glycopyrrolate/…

The Differential Effects of Inhaled and Oral Corticosteroids on Type-2 Inflammation in the Blood and Airway Compartments of Eosinophilic Asthmatics

J Melhorn, C Pelaia, G Hynes, N Petousi… - C31. WHAT'S NEW IN …, 2024 - atsjournals.org
51 天前 - … with additive predictive value in asthma exacerbation risk. We have shown that
high … hypothesis that low dose inhaled corticosteroids and oral corticosteroids, both effective …

Predicting Severe Asthma Attacks With Blood Eosinophils and Exhaled Nitric Oxide (FeNO): Initial Data Analysis for the ORACLE Patient-level Meta-analysis

S Couillard, FL Meulmeester… - C31. WHAT'S NEW IN …, 2024 - atsjournals.org
51 天前 - … Cochrane Risk-of-Bias Tool for RCTs. Study sponsors were contacted to request
anonymised IPD for patients randomised to the trials’ control arms (ie no inhaled corticosteroid

Risks of Long Term Inhaled Corticosteriod Use in COPD Management and Need to Assess Benefits Versus Risks

WD Pace, E Callen, G Gaona-Villarreal… - B52. EVIDENCE FOR …, 2024 - atsjournals.org
51 天前 - inhaled corticosteroid (ICS) with a long-acting beta agonist (LABA) differing from
current recommendations for inhaled … Selecting therapy should be based on informed risk and …